Paul E. Zarek

Array ( [id] => 6031080 [patent_doc_number] => 20110081365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'COMPOUNDS AND COMPOSITIONS AS TLR ACTIVITY MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/921129 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 122852 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081365.pdf [firstpage_image] =>[orig_patent_app_number] => 12921129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 102873 [patent_doc_number] => 07723385 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Aniline derivatives as selective androgen receptor modulators' [patent_app_type] => utility [patent_app_number] => 12/392687 [patent_app_country] => US [patent_app_date] => 2009-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28914 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723385.pdf [firstpage_image] =>[orig_patent_app_number] => 12392687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5380359 [patent_doc_number] => 20090192198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME' [patent_app_type] => utility [patent_app_number] => 12/390318 [patent_app_country] => US [patent_app_date] => 2009-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 45135 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192198.pdf [firstpage_image] =>[orig_patent_app_number] => 12390318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097674 [patent_doc_number] => 20110003797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'HEXAHYDROCYCLOPENTYL[f]INDAZOLE CARBOXAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/919049 [patent_app_country] => US [patent_app_date] => 2009-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14731 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003797.pdf [firstpage_image] =>[orig_patent_app_number] => 12919049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343787 [patent_doc_number] => 20100330136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'USE OF CATIONIC SURFACTANTS FOR THE PROTECTION AGANST TOOTH EROSION' [patent_app_type] => utility [patent_app_number] => 12/812813 [patent_app_country] => US [patent_app_date] => 2009-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3918 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330136.pdf [firstpage_image] =>[orig_patent_app_number] => 12812813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5534137 [patent_doc_number] => 20090233925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Hepatitis C Virus Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/368465 [patent_app_country] => US [patent_app_date] => 2009-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41402 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233925.pdf [firstpage_image] =>[orig_patent_app_number] => 12368465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8201234 [patent_doc_number] => 08188131 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Compounds that enhance Atoh1 expression' [patent_app_type] => utility [patent_app_number] => 12/368173 [patent_app_country] => US [patent_app_date] => 2009-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 87 [patent_figures_cnt] => 212 [patent_no_of_words] => 34015 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188131.pdf [firstpage_image] =>[orig_patent_app_number] => 12368173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480732 [patent_doc_number] => 20090203689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'ABCA-1 ELEVATING COMPOUNDS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/367062 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22464 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203689.pdf [firstpage_image] =>[orig_patent_app_number] => 12367062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097937 [patent_doc_number] => 20110003842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'MARKER FOR DETERMINATION OF SENSITIVITY TO ANTI-CANCER AGENT' [patent_app_type] => utility [patent_app_number] => 12/865725 [patent_app_country] => US [patent_app_date] => 2009-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6167 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003842.pdf [firstpage_image] =>[orig_patent_app_number] => 12865725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9983698 [patent_doc_number] => 09029411 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-12 [patent_title] => 'Thiophenes and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/321871 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21285 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12321871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9227583 [patent_doc_number] => 08633251 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-21 [patent_title] => 'Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use' [patent_app_type] => utility [patent_app_number] => 12/863881 [patent_app_country] => US [patent_app_date] => 2009-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 22287 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12863881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495113 [patent_doc_number] => 20100009986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'SUBSTITUTED HETEROARYL DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/373947 [patent_app_country] => US [patent_app_date] => 2007-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 134523 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20100009986.pdf [firstpage_image] =>[orig_patent_app_number] => 12373947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239271 [patent_doc_number] => 08604063 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies' [patent_app_type] => utility [patent_app_number] => 12/811931 [patent_app_country] => US [patent_app_date] => 2009-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13442 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12811931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6449185 [patent_doc_number] => 20100280127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'INHIBITING NEUROTRANSMITTER REUPTAKE' [patent_app_type] => utility [patent_app_number] => 12/812337 [patent_app_country] => US [patent_app_date] => 2009-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 27876 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20100280127.pdf [firstpage_image] =>[orig_patent_app_number] => 12812337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5343282 [patent_doc_number] => 20090181932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'COMPOSITIONS CONTAINING O-SULFATE AND O-PHOSPHATE CONTAINING ARYL SULFONAMIDE DERIVATIVES USEFUL AS beta-AMYLOID INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/349850 [patent_app_country] => US [patent_app_date] => 2009-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8868 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181932.pdf [firstpage_image] =>[orig_patent_app_number] => 12349850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6433867 [patent_doc_number] => 20100278828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'COMBINATION OF ANTI-CTLA4 ANTIBODY WITH TUBULIN MODULATING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/811867 [patent_app_country] => US [patent_app_date] => 2009-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18314 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278828.pdf [firstpage_image] =>[orig_patent_app_number] => 12811867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9850342 [patent_doc_number] => 08952071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-10 [patent_title] => '(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases' [patent_app_type] => utility [patent_app_number] => 12/811694 [patent_app_country] => US [patent_app_date] => 2009-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28078 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12811694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5316558 [patent_doc_number] => 20090281156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'ENHANCING PHOTOSTABILIZATION OF OXYMETAZOLINE' [patent_app_type] => utility [patent_app_number] => 12/339394 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5162 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281156.pdf [firstpage_image] =>[orig_patent_app_number] => 12339394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6544937 [patent_doc_number] => 20100016279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'BICYCLIC DERIVATIVES FOR USE IN THE TREATMENT OF ANDROGEN RECEPTOR ASSOCIATED CONDITIONS-155' [patent_app_type] => utility [patent_app_number] => 12/338405 [patent_app_country] => US [patent_app_date] => 2008-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 156761 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016279.pdf [firstpage_image] =>[orig_patent_app_number] => 12338405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502814 [patent_doc_number] => 20090163502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists' [patent_app_type] => utility [patent_app_number] => 12/317026 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38805 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20090163502.pdf [firstpage_image] =>[orig_patent_app_number] => 12317026 [rel_patent_id] =>[rel_patent_doc_number] =>)